Drug Registration Bureaucracy Persists Despite Digitalization, Say Business Leaders

Business leaders have stated that the sanitary registration process for medicines continues to be bogged down by bureaucracy, even after the implementation of digitalization efforts. During a hearing at Congress, they explained that the supposed simplification of procedures for sanitary registration is merely a digital conversion of existing documents, rather than a fundamental streamlining of the process. This means that while the submission might be electronic, the underlying requirements and the time it takes to get approval remain largely unchanged. The entrepreneurs emphasized that this lack of genuine procedural reform hinders their ability to bring new medications to market efficiently. They are calling for more substantial changes that would truly reduce the administrative burden. The current system, they argue, still involves extensive paperwork and lengthy review periods, despite the outward appearance of modernization. This situation creates a significant obstacle for pharmaceutical companies operating in the country. The business community believes that a more efficient registration system is crucial for public health, as it would allow for faster access to necessary treatments.